SCHEMBL3650385

SCHEMBL3650385

NCC(=O)OC(=O)[C@@H](N)CC(N)=O.NCCCC[C@H](N)C(=O)OC[C@H](N)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.46
CPB2 Q96IY4 1/20 0.33
RNPEP Q9H4A4 1/20 0.33
NOS2 P35228 6/20 0.31
NOS1 P29475 5/20 0.31
NOS3 P29474 3/20 0.31
CYP1A2 P05177 2/20 0.31
TSHR P16473 2/20 0.31
CYP3A4 P08684 1/20 0.31
ARG2 P78540 4/20 0.31
ARG1 P05089 3/20 0.31
BLM P54132 2/20 0.31
ALOX15 P16050 1/20 0.31
PMP22 Q01453 1/20 0.31
KMT2A Q03164 1/20 0.31
DDAH1 O94760 1/20 0.31
GLA P06280 1/20 0.31
NFKB1 P19838 1/20 0.31
APEX1 P27695 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL8885814 0.85 GSR (0.48) GSRRNPEPNOS2NOS1NOS3
SCHEMBL9780155 0.82 GSR (0.68) GSRCPB2RNPEPNOS2NOS1
SCHEMBL2821897 0.82 GSR (0.68) GSRCPB2RNPEPNOS2NOS1
Lysine SCHEMBL5410772 0.82 GSR (0.53) GSRCPB2NOS2NOS1NOS3
SCHEMBL1389422 0.81 GSR (0.50) GSRCPB2RNPEPDPP8DPP9
Lysine SCHEMBL15283763 0.81 GSR (0.71) GSRCPB2RNPEPNOS2NOS1
SCHEMBL21988570 0.81 GSR (0.53) GSRCPB2RNPEPCYP1A2DPP8
SCHEMBL845919 0.81 GSR (0.53) GSRCPB2RNPEPCYP1A2DPP8
Lysine SCHEMBL2385063 0.80 GSR (0.42) GSRNOS2NOS1NOS3CYP1A2
Lysine SCHEMBL8199478 0.80 GSR (0.65) GSRCPB2RNPEPNOS2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183598-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING SUBSTRATE SPECIFICITY OF INHIBITORS OF GAMMA SECRETASE Elan Pharmaceuticals Inc. (US) 2010-05-12 EP disclosed
US-20090163594-A1 Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors ELAN PHARMACEUTICALS, INC. (US) 2009-06-25 US disclosed
US-20090023158-A1 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase ELAN PHARMACEUTICALS, INC. (US) 2009-01-22 US disclosed
WO-2009012237-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING SUBSTRATE SPECIFICITY OF INHIBITORS OF GAMMA SECRETASE ELAN PHARMACEUTICALS, INC. (US) 2009-01-22 WO disclosed